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Melanocortin 1 Receptor Function:
Shifting Gears from Determining Skin
and Nevus Phenotype to Fetal Growth
Nelleke A. Gruis1 and Remco van Doorn1
Variants in the MC1R gene influence skin pigmentation and thereby modulate
risk of melanoma and basal and squamous cell carcinoma. In this issue, Kinsler
et al. report an association between the MC1R genotype and the development
of congenital melanocytic nevi. Further, higher birth weight was observed in
carriers of MC1R variants, suggesting a role for the melanocortin network in
fetal growth.
Journal of Investigative Dermatology (2012) 132, 1953–1955. doi:10.1038/jid.2012.216
Melanocortin 1 receptor functioning and
genetic variants
The human MC1R gene, located on
chromosome 16q24.3, is highly poly-
morphic. The gene encodes for a G
protein–coupled melanocortin 1 receptor
that is expressed in melanocytes and other
cell types that reside in the skin, including
keratinocytes and fibroblasts, as well as
cells of the immune system.
The major agonists of MC1R are clea-
vage products of proopiomelanocortin,
and they include the melanocyte-stimu-
lating hormones (MSHs) and adrenocor-
ticotrophin. In particular, MC1R has high
affinity for a-MSH, which acts in an
autocrine and paracrine manner.
Activation of MC1R by a-MSH leads
to an increase of cAMP, ultimately
leading to complete activation of the
promoter of the microphthalmia tran-
scription factor (MITF) gene. MITF has a
key role in the control of melanogenesis,
leading to increased transcription of
a range of genes including TYR and
TYRP1, which are involved in the con-
trol of the relative and absolute amounts
of eumelanin and pheomelanin pigment
in the skin. The MITF transcription factor
has many other transcriptional targets,
including BCL2, MET, and HIF1A (Cheli
et al., 2010). Robbins et al. (1993)
first described the association of MC1R
variants and receptor functionality in
modulating the fur color of mice. Soon
thereafter, studies on the functionality
of MC1R variants were carried out in
humans. Population studies revealed
that several MC1R variants are associ-
ated with red hair and fair skin, desig-
nated as red hair color (RHC) and fair
skin variants. Interestingly, the variant
alleles differ in their penetrance concern-
ing the RHC phenotype (Sturm, 2002).
The common variants R151C, R160W,
and D294H and the rarely occurring
variants D84E and R142H are strongly
associated with the red hair phenotype
in the Caucasian population, with odds
ratios of 50- to 120-fold (referred to
as (strong) R variants). The weak RHC
alleles V60L, V92M, and R163Q have
odds ratios for red hair between 2 and 6
and are therefore considered to be
(weak) r variants. Soon after the corre-
lations were observed between MC1R
variants and the RHC phenotype, asso-
ciations were observed between these
variants and other skin-related pheno-
types, such a risk of developing mela-
noma and non-melanoma skin cancer,
as well as freckles (Sturm, 2002). Interest-
ingly, associated odds ratios increased
when more RHC variants were present
in the genotype, with homozygous R
variants conferring the highest risk.
Despite the fact that more than 100
variants in the MC1R gene have been
identified to date, the consequences of
these variants on the physiological func-
tion of MC1R have been defined only
partially (Dessinioti et al., 2011). RHC
variants R151C, R160W, and D294H
have been defined as strong RHC (R)
variants based not only on their signifi-
cant associations with specific pheno-
typic features, such as red hair, fair
skin, and freckling, but also on their
diminished receptor function, reduced
response to a-MSH, and reduced func-
tional coupling of MC1R to adenylate
cyclase in vitro. The functional relevance
of the weaker (low penetrant) RHC (r)
variants, such as V60L, V92M, and
R163Q, is still a matter of debate, with
some reports pointing to a minor signal-
ing impairment, and others showing
a behavior similar to that of wild-type
MC1R (Dessinioti et al., 2011). One
report suggested that the V92M substitu-
tion reduces the binding affinity of MC1R
for a-MSH, whereas another found no
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alteration in the functional coupling
of the receptor to adenylate cyclase.
Transfection studies have suggested that
the V60L variant differs significantly from
the wild-type MC1R in its ability to
stimulate intracellular cAMP and that
the V92M variant has a 2-fold lower
affinity for a-MSH than does wild-type
MC1R.
The most acknowledged readout of
the functional alteration of MC1R is
an altered balance of eumelanin and
pheomelanin, determing skin type and
the ability to tan. Activation of MC1R by
a-MSH has functions in the skin other
than regulation of melanin biosynthesis.
In melanocytes, it reduces oxidative
DNA damage caused by UV radia-
tion (Kadekaro et al., 2010). Signaling
through MC1R impacts on inflammatory
responses in the skin by downregula-
ting production of pro-inflammatory
cytokines by immune cells (Brzoska
et al., 2008). It also influences extracel-
lular matrix composition by modulating
the synthesis of collagens by dermal
fibroblasts. Biological processes regula-
ted by MC1R are not limited to the skin
and include modulation of pain sensation
in the nervous system and cartilage
differentiation (Gra¨ssel et al., 2009).
Therefore, it is not surprising that the
phenotypic effects of variant MC1R
alleles are numerous.
A role for MC1R variants in fetal
nevogenesis
Kinsler et al. (this issue, 2012) report a
high prevalence of individuals with red
hair and freckles in families with con-
genital melanocytic nevi (CMN). Owing
to the red hair and abundant freckling
phenotype present in CMN families, an
association with MC1R genotype was
investigated. Individuals with CMN
were observed to carry two MC1R
variant alleles more frequently than
controls (P¼0.0052).
It was furthermore noted that patients
with CMN and a family history of CMN
had a higher prevalence of at least one
MC1R variant compared with those who
lacked a first- or second-degree relative
with CMN. More precisely, a prepon-
derance of V92M and/or R allele (D84E,
R151C, R160W, D294H) was observed
in children with a CMN and a family
history of CMN versus those without the
family history or controls.
For those patients with a large pig-
mented birthmark, which can affect up
to 80% of the skin surface area, a size
prediction at adulthood (projected adult
size: PAS) can be made. In the CMN
cohort, the presence of V92M or an R
was found to be associated with increas-
ing PAS of the largest CMN (P¼ 0.01).
PAS 460 cm is regarded as a risk factor
for cutaneous malignant melanoma.
The odds ratio for having a CMN
of PAS 460 cm compared with those
of o60 cm, if carrying V92M or an
R allele, was 2.9 (95% CI 1.13–6.54,
P¼0.012). Whereas inactive variants
of MC1R are reported to predispose
to the development of CMN, para-
doxically activation of MC1R by admi-
nistered synthetic a-MSH in adults can
elicit the development of eruptive mela-
nocytic nevi (Cardones and Grichnik,
2009).
MC1R and fetal development
Kinsler et al. (2012) hypothesized that
if MC1R variants are associated with
growth of moles, variants might also
be associated with fetal growth in
general. An association was observed
between the V92M or R151C allele and
increased birth weight, irrespective of
the presence of CMN. The effect was no
longer present at 49 months after birth,
suggesting a growth-promoting effect of
specific MC1R variants during embryo-
genesis only. Birth weight is a complex
trait influenced by many factors, of
which the most significant are gesta-
tional and maternal age, body mass
index, parity, smoking, and socioeco-
nomic status. From a large genome-
wide association study of birth weight,
a small number of polymorphic loci in
the ADCY5 gene and near the CCNL1
gene have emerged associated with
birth weight (Freathy et al., 2010). The
inferred relationship between the
MC1R variant carriage and higher birth
weight might not necessarily be causal,
as adjustments have not been made
for all implicated factors. The relation-
ship could potentially be indirect; by
affecting cutaneous responses to UV
radiation, the maternal MC1R geno-
type could, for instance, affect vitamin
D levels, which are known to be asso-
ciated with fetal growth and birth
weight (Bodnar et al., 2010).
Effects of polymorphisms
in the MC1R gene
extend beyond
pigmentation to
include melanoma
and birth weight.
Thus far, the known consequences of
MC1R variants on functioning of the
melanocortin 1 receptor in melanocytes
are more or less all related to alterations
in pigment synthesis and its associated
defense against UV-induced genotoxic
stress. Few studies on the effect of
variants on proliferation have been pub-
lished. Stanisz et al. (2011) investigated
in both melanocyte and fibroblast cell
lines with wild-type and different MC1R
variants the effect of stimulation with
a-MSH on intracellular cAMP and cellular
proliferation. MC1R stimulation with
a-MSH in wild-type (MC1R(wt)) melano-
cytes resulted in an increase of intracel-
lular cAMP and cellular proliferation. In
contrast, MC1R(wt) fibroblasts responded
with decreased intracellular cAMP and
proliferation. In MC1R polymorphic
fibroblasts (R163Q, R151C, and V60L),
both effects were significantly diminished.
Similar, but inverse, effects were found in
MC1R polymorphic melanocytes (R142H
and V92M), with significantly lower
cAMP increases and proliferation rates
compared with MC1R(wt) melanocytes.
These results indicate that MC1R displays
reciprocal growth responses in melano-
cytes and fibroblasts, depending on the
MC1R genotype. Furthermore, MC1R
seems to be important not only for the
skin pigmentary system in melanocytes
but also for fibroblast function, and it
might influence different processes of the
dermal compartment, such as wound
healing, fibrosis, and keloid formation.
How these proliferative effects of MC1R
variants on skin cells might relate to birth
weight is not well understood.
With respect to other cell types influ-
encing birth weight, one might consi-
der adipocytes. Interestingly, MC1R
belongs to a family of the G protein–
coupled receptors (family A), for which
five subtypes have been described
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(MC1R–MC5R). Of these, MC2R and
MC5R have been proposed to act
directly in adipocytes and to regulate
lipolysis in rodents (Mller et al., 2011).
a-MSH-stimulated lipolysis is mediated
through MC5R in a cAMP-independent
manner. This suggests that more cAMP-
independent functions can be anticipa-
ted for MC1R, but a role for MC1R in
adipocytes (and, thereby, influencing
birth weight) has not yet been shown.
The findings by Kinsler et al. (2012)
expand the known phenotypical varia-
tions associated with polymorphisms in
the MC1R gene.
CONFLICT OF INTEREST
The authors state no conflict of interest.
REFERENCES
Bodnar LM, Catov JM, Zmuda JM et al. (2010)
Maternal serum 25-hydroxyvitamin D con-
centrations are associated with small-
for-gestational age births in white women.
J Nutr 140:999–1006
Brzoska T, Luger TA, Maaser C et al. (2008) Alpha-
melanocyte-stimulating hormone and related
tripeptides: biochemistry, antiinflammatory
and protective effects in vitro and in vivo,
and future perspectives for the treatment of
immune-mediated inflammatory diseases.
Endocr Rev 29:581–602
Cardones AR, Grichnik JM (2009) a-Melanocyte-
stimulating hormone-induces eruptive. Nevi
Arch Dermatol 145:441–4
Cheli Y, Ohanna M, Ballotti R et al. (2010) Fifteen-
year quest for microphthalmia-associated
transcription factor target genes. Pigment Cell
Melanoma Res 23:27–40
Dessinioti C, Antoniou C, Katsambas A et al.
(2011) Melanocortin 1 receptor variants: func-
tional role and pigmentary associations.
Photochem Photobiol 87:978–87
Freathy RM, Mook-Kanamori DO, Sovio U
et al. (2010) Variants in ADCY5 and near
CCNL1 are associated with fetal growth and
birth weight. Nat Genet 42:430–5
Gra¨ssel S, Opolka A, Anders S et al. (2009) The
melanocortin system in articular chondrocytes:
melanocortin receptors, pro-opiomelanocortin,
precursor proteases, and a regulatory effect of
alpha-melanocyte-stimulating hormone on pro-
inflammatory cytokines and extracellular matrix
components. Arthritis Rheum 60:3017–27
Kadekaro AL, Leachman S, Kavanagh RJ et al.
(2010) Melanocortin 1 receptor genotype: an
important determinant of the damage
response of melanocytes to ultraviolet radia-
tion. FASEB J 24:3850–60
Kinsler VA, Abu-Amero S, Budd P et al. (2012) Severity
of cutaneous phenotype in congenital melano-
cytic nevi: a role for MC1R in human fetal
development. J Invest Dermatol 132:2026–32
Mller CL, Raun K, Jacobsen ML et al. (2011)
Characterization of murine melanocortin
receptors mediating adipocyte lipolysis and
examination of signalling pathways involved.
Mol Cell Endocrinol 341:9–17
Robbins LS, Nadeau JH, Johnson KR et al. (1993)
Pigmentation phenotypes of variant extension
locus alleles result from point mutations that
alter MSH receptor function. Cell 72:827–34
Stanisz H, Seifert M, Tilgen W et al. (2011)
Reciprocal responses of fibroblasts and mela-
nocytes to a-MSH depending on MC1R poly-
morphisms. Dermatoendocrinol 3:259–65
Sturm RA (2002) Skin colour and skin cancer -
MC1R, the genetic link. Melanoma Res
12:405–16
Toll-Like Receptors in Wound Healing:
Location, Accessibility, and Timing
Mohan R. Dasu1 and R. Rivkah Isseroff1
Toll-like receptors (TLRs) are considered to be the first responders in the defense
against invading pathogens. TLR engagement by ligands triggers inflammatory
responses in injury and trauma, and thus can impair or contribute to the healing
process, depending on TLRs’ expression pattern, cellular localization, signaling,
and deployment of inflammatory responses. Understanding these attributes could
improve therapeutic strategies for treating chronic wounds.
Journal of Investigative Dermatology (2012) 132, 1955–1958. doi:10.1038/jid.2012.208
Toll-like receptor (TLR) activation and
signaling
The interaction of multiple cell types—
and their activation in the inflammatory,
proliferative, and remodeling phases of
cutaneous wound healing—is orche-
strated by the temporo-spatially con-
strained expression of a host of cyto-
kines and growth factors. Lin et al. 2012,
this issue highlight yet another class of
mediators, contributing a new melody
to the expanding symphony of wound
healing modulation: TLR, activators of
the innate immunity. Although the cur-
rent report focuses on the role of TLR3, it
is worthwhile to examine the complex
interactions of TLRs in wound repair.
TLRs present on immune cells such as
macrophages, neutrophils, and dendritic
cells recognize bacterial and fungal com-
ponents (cell surface: TLRs1–6), whereas
intracellular TLRs recognize viral double-
stranded RNA (TLR3), viral single-stran-
ded RNA (TLR7 and TLR8), and micro-
bial DNA (TLR9) (Kenny and O’Neill,
2008). In addition, TLRs can interact with
endogenous ligands produced by stres-
sed, injured, or damaged cells, such as
heat shock proteins 60 and 70, fibrino-
gen, and fibronectin (Mollen et al.,
2006). Thus, TLRs provide a system for
an immunomodulatory response to a host
of potential pathogens or endogenous
signals of cell stress.
When a TLR ligand binds to its
receptor, one of two events takes place:
either a receptor dimer is formed or the
conformation of a pre-existing dimer
changes in such a way that it brings
two intracellular Toll-IL-1 receptor
(TIR) domains of the TLRs to interact
physically. This simple rearrangement
facilitates the nucleating act for the
recruitment of downstream signaling
adaptor proteins (Manavalan et al.,
2011). Signaling cascades via the intra-
cellular TIR domains are mediated by
specific adaptor molecules such as
MyD88 (myeloid differentiation factor 88),
Mal (MyD88 adaptor-like), TRIF (TIR
See related article on pg 2085
1Department of Dermatology, VA Northern California Health Care Systems, and the University of
California, Davis, California, USA
Correspondence: R. Rivkah Isseroff, Department of Dermatology, VA Northern California Health Care
Systems, and the University of California, One Shields Ave, TB 192, Davis, California 95616, USA.
E-mail: rrisseroff@ucdavis.edu
COMMENTARY
www.jidonline.org 1955
